The Liquid Biopsy and Tumor Progression in Breast Cancer
21 – 30 of 115
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Risk-adjusted benchmarking of long-term overall survival in patients with HER2-positive early-stage Breast cancer : A Swedish retrospective cohort study
(
- Contribution to journal › Article
-
Mark
Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study
(
- Contribution to journal › Article
-
Mark
Noninvasive Staging of Lymph Node Status in Breast Cancer Using Machine Learning : External Validation and Further Model Development
(
- Contribution to journal › Article
- 2022
-
Mark
Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes
(
- Contribution to journal › Article
-
Mark
Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN)
(
- Contribution to journal › Article
-
Mark
The Prognostic Role of Intratumoral Stromal Content in Lobular Breast Cancer
(
- Contribution to journal › Article
-
Mark
Prediction of node negative breast cancer and high disease burden through image analysis software on mammographic images and clinicopathological data
2022)(
- Contribution to conference › Abstract
-
Mark
Autoimmunity to selenoprotein P predicts breast cancer recurrence
(
- Contribution to journal › Article
-
Mark
Feasibility and Relevance of an Intervention with Systematic Screening as a Base for Individualized Rehabilitation in Breast Cancer Patients : A Pilot Trial of the ReScreen Randomized Controlled Trial
(
- Contribution to journal › Article
-
Mark
One-year recovery from breast cancer : Importance of tumor and treatment-related factors, resilience, and sociodemographic factors for health-related quality of life
(
- Contribution to journal › Article